Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 11 | 2022 | 1267 | 2.400 |
Why?
|
Myeloproliferative Disorders | 8 | 2022 | 607 | 2.180 |
Why?
|
Laboratory Proficiency Testing | 7 | 2022 | 32 | 2.120 |
Why?
|
Hematologic Neoplasms | 8 | 2022 | 1701 | 1.590 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 2 | 2021 | 92 | 1.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 12 | 2022 | 3698 | 1.370 |
Why?
|
Bone Marrow | 9 | 2020 | 2959 | 1.210 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 198 | 1.160 |
Why?
|
Leukemia, Myeloid, Acute | 12 | 2022 | 3333 | 1.150 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2019 | 236 | 1.120 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2019 | 1949 | 1.100 |
Why?
|
Pathology, Molecular | 6 | 2022 | 346 | 1.070 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 2 | 2015 | 114 | 1.050 |
Why?
|
MicroRNAs | 6 | 2021 | 3680 | 0.980 |
Why?
|
RNA, Transfer | 2 | 2017 | 313 | 0.980 |
Why?
|
Lymphoma | 2 | 2022 | 1889 | 0.950 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 1671 | 0.920 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2016 | 239 | 0.840 |
Why?
|
Nuclear Envelope | 1 | 2021 | 177 | 0.760 |
Why?
|
Pancytopenia | 1 | 2019 | 106 | 0.720 |
Why?
|
Lymphopenia | 1 | 2021 | 282 | 0.700 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 50 | 0.690 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2019 | 120 | 0.690 |
Why?
|
Histiocytes | 1 | 2018 | 104 | 0.670 |
Why?
|
Eosinophilia | 1 | 2022 | 513 | 0.660 |
Why?
|
Langerhans Cells | 1 | 2018 | 178 | 0.650 |
Why?
|
Vascular Neoplasms | 1 | 2019 | 183 | 0.650 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 1308 | 0.650 |
Why?
|
Blood Cells | 1 | 2019 | 322 | 0.650 |
Why?
|
Laboratories | 2 | 2022 | 441 | 0.590 |
Why?
|
Bone Marrow Neoplasms | 2 | 2016 | 109 | 0.580 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1779 | 0.580 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2017 | 176 | 0.560 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2017 | 3016 | 0.540 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 356 | 0.480 |
Why?
|
Mutation | 13 | 2022 | 29491 | 0.470 |
Why?
|
Multiple Myeloma | 5 | 2022 | 5167 | 0.470 |
Why?
|
Neoplasms | 8 | 2022 | 20572 | 0.460 |
Why?
|
Burkitt Lymphoma | 1 | 2015 | 365 | 0.450 |
Why?
|
Chromosome Aberrations | 3 | 2018 | 1826 | 0.450 |
Why?
|
Leukocytes | 1 | 2021 | 2103 | 0.450 |
Why?
|
Metaphase | 1 | 2012 | 165 | 0.450 |
Why?
|
Pathology, Clinical | 3 | 2020 | 372 | 0.420 |
Why?
|
Bone Marrow Cells | 4 | 2016 | 2593 | 0.420 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2012 | 278 | 0.410 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2018 | 2661 | 0.380 |
Why?
|
Chromosome Disorders | 1 | 2012 | 498 | 0.370 |
Why?
|
Genetic Testing | 2 | 2019 | 3340 | 0.370 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2012 | 275 | 0.360 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2022 | 1567 | 0.340 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2008 | 36 | 0.340 |
Why?
|
Blast Crisis | 1 | 2008 | 106 | 0.330 |
Why?
|
Neutrophils | 1 | 2021 | 3816 | 0.330 |
Why?
|
Hematopoiesis | 4 | 2022 | 2019 | 0.320 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 1471 | 0.310 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 2 | 2021 | 165 | 0.300 |
Why?
|
Humans | 66 | 2022 | 717280 | 0.290 |
Why?
|
Gene Rearrangement | 2 | 2022 | 1208 | 0.290 |
Why?
|
Bone Marrow Examination | 3 | 2015 | 165 | 0.290 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2031 | 0.280 |
Why?
|
Karyotyping | 5 | 2018 | 1272 | 0.280 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1011 | 0.270 |
Why?
|
Skin | 1 | 2018 | 4355 | 0.260 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5152 | 0.260 |
Why?
|
Paraffin Embedding | 2 | 2018 | 319 | 0.250 |
Why?
|
Cell Differentiation | 2 | 2018 | 11762 | 0.230 |
Why?
|
Promoter Regions, Genetic | 2 | 2021 | 6051 | 0.230 |
Why?
|
Leukemoid Reaction | 1 | 2022 | 18 | 0.230 |
Why?
|
Pyrimidines | 2 | 2020 | 2974 | 0.230 |
Why?
|
Plasma Cells | 2 | 2017 | 610 | 0.220 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 12435 | 0.210 |
Why?
|
Biopsy | 5 | 2018 | 6753 | 0.210 |
Why?
|
HL-60 Cells | 1 | 2021 | 372 | 0.200 |
Why?
|
DNA Methylation | 2 | 2021 | 4102 | 0.200 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2021 | 166 | 0.190 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 122 | 0.190 |
Why?
|
Blood Cell Count | 1 | 2021 | 420 | 0.190 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 288 | 0.190 |
Why?
|
Fanconi Anemia | 1 | 2022 | 324 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17432 | 0.180 |
Why?
|
Cell Size | 1 | 2021 | 660 | 0.180 |
Why?
|
Middle Aged | 19 | 2022 | 215054 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2020 | 191 | 0.180 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5335 | 0.180 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2021 | 1615 | 0.170 |
Why?
|
Clone Cells | 2 | 2020 | 1760 | 0.170 |
Why?
|
Gene Fusion | 1 | 2021 | 376 | 0.170 |
Why?
|
Spliceosomes | 1 | 2018 | 109 | 0.170 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 518 | 0.170 |
Why?
|
Cytogenetics | 2 | 2016 | 215 | 0.170 |
Why?
|
Male | 23 | 2021 | 351399 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 682 | 0.160 |
Why?
|
Mastocytosis | 1 | 2020 | 152 | 0.160 |
Why?
|
Genes, erbB-1 | 1 | 2018 | 170 | 0.160 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2210 | 0.160 |
Why?
|
Disease Progression | 5 | 2022 | 13308 | 0.160 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 628 | 0.160 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 645 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13754 | 0.160 |
Why?
|
Translocation, Genetic | 2 | 2014 | 1426 | 0.160 |
Why?
|
Aged, 80 and over | 9 | 2021 | 58528 | 0.160 |
Why?
|
Piperazines | 1 | 2008 | 2543 | 0.160 |
Why?
|
Aged | 14 | 2021 | 162862 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2018 | 257 | 0.160 |
Why?
|
Medical Oncology | 2 | 2019 | 2124 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2021 | 1669 | 0.150 |
Why?
|
Immunophenotyping | 2 | 2015 | 1904 | 0.150 |
Why?
|
Leukemia | 2 | 2021 | 1529 | 0.150 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2020 | 486 | 0.150 |
Why?
|
Syndecan-1 | 1 | 2017 | 179 | 0.150 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1729 | 0.150 |
Why?
|
Immunohistochemistry | 4 | 2015 | 11777 | 0.140 |
Why?
|
Colonic Diseases | 1 | 2017 | 209 | 0.140 |
Why?
|
Thiophenes | 1 | 2020 | 603 | 0.140 |
Why?
|
Metformin | 1 | 2022 | 805 | 0.140 |
Why?
|
Cyclin D1 | 1 | 2017 | 469 | 0.140 |
Why?
|
Molecular Biology | 1 | 2019 | 576 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 796 | 0.140 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14904 | 0.140 |
Why?
|
Genes, ras | 1 | 2018 | 720 | 0.140 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 714 | 0.140 |
Why?
|
Neoplasm, Residual | 2 | 2018 | 996 | 0.130 |
Why?
|
Workflow | 1 | 2019 | 817 | 0.130 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2014 | 93 | 0.130 |
Why?
|
Down Syndrome | 1 | 2022 | 813 | 0.130 |
Why?
|
Female | 19 | 2021 | 377934 | 0.130 |
Why?
|
Sulfonamides | 2 | 2021 | 1932 | 0.130 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4312 | 0.130 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9532 | 0.130 |
Why?
|
Receptors, Transferrin | 1 | 2015 | 290 | 0.130 |
Why?
|
Antigens, CD | 2 | 2015 | 4157 | 0.120 |
Why?
|
Erythroid Cells | 1 | 2015 | 252 | 0.120 |
Why?
|
Reproducibility of Results | 5 | 2022 | 19537 | 0.120 |
Why?
|
Mouth Mucosa | 1 | 2016 | 432 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 184 | 0.120 |
Why?
|
Stem Cell Niche | 1 | 2016 | 342 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1635 | 0.120 |
Why?
|
Perforin | 1 | 2013 | 171 | 0.120 |
Why?
|
Medical Informatics | 1 | 2020 | 738 | 0.120 |
Why?
|
Incidental Findings | 1 | 2017 | 667 | 0.120 |
Why?
|
Adult | 15 | 2022 | 212470 | 0.120 |
Why?
|
Oncogene Proteins | 1 | 2017 | 764 | 0.110 |
Why?
|
World Health Organization | 1 | 2018 | 1287 | 0.110 |
Why?
|
Chromosome Banding | 1 | 2012 | 284 | 0.110 |
Why?
|
Macrophage Activation Syndrome | 1 | 2013 | 101 | 0.110 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2017 | 750 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4916 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13276 | 0.100 |
Why?
|
Leukemia, Myeloid | 1 | 2014 | 730 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2161 | 0.100 |
Why?
|
Lymphoma, Follicular | 1 | 2014 | 420 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 2827 | 0.100 |
Why?
|
Ferritins | 1 | 2013 | 581 | 0.100 |
Why?
|
Tretinoin | 1 | 2013 | 530 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2721 | 0.090 |
Why?
|
Remission Induction | 2 | 2022 | 2391 | 0.090 |
Why?
|
Colonoscopy | 1 | 2017 | 1315 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1747 | 0.090 |
Why?
|
CpG Islands | 1 | 2013 | 1162 | 0.090 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2008 | 44 | 0.090 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1378 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3511 | 0.090 |
Why?
|
Disease Management | 1 | 2019 | 2538 | 0.090 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1997 | 0.080 |
Why?
|
Critical Illness | 1 | 2021 | 2543 | 0.080 |
Why?
|
Histones | 1 | 2018 | 2588 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1195 | 0.080 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 380 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 558 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2012 | 1892 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1393 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7486 | 0.080 |
Why?
|
Curriculum | 1 | 2020 | 3404 | 0.080 |
Why?
|
Mitochondria | 1 | 2020 | 3642 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3703 | 0.080 |
Why?
|
Glioblastoma | 1 | 2021 | 3357 | 0.070 |
Why?
|
Base Sequence | 2 | 2015 | 13317 | 0.070 |
Why?
|
Hematology | 2 | 2020 | 200 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1391 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4356 | 0.070 |
Why?
|
Signal Transduction | 4 | 2020 | 23997 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5271 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3471 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 776 | 0.070 |
Why?
|
Young Adult | 5 | 2022 | 56249 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5988 | 0.060 |
Why?
|
Aldehydes | 1 | 2005 | 194 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4825 | 0.060 |
Why?
|
Propanolamines | 1 | 2004 | 167 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2022 | 4846 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4935 | 0.060 |
Why?
|
Receptor, IGF Type 1 | 1 | 2005 | 403 | 0.060 |
Why?
|
Philadelphia Chromosome | 1 | 2022 | 108 | 0.060 |
Why?
|
Carbazoles | 1 | 2004 | 238 | 0.060 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 16989 | 0.060 |
Why?
|
Ataxia Telangiectasia | 1 | 2022 | 100 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 8944 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3993 | 0.060 |
Why?
|
Benzamides | 1 | 2008 | 1414 | 0.060 |
Why?
|
Recurrence | 3 | 2022 | 8284 | 0.060 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2021 | 14 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2485 | 0.050 |
Why?
|
Patient Care Team | 1 | 2013 | 2596 | 0.050 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 993 | 0.050 |
Why?
|
Sepsis | 1 | 2015 | 2460 | 0.050 |
Why?
|
Algorithms | 2 | 2020 | 13716 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3778 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 2 | 2022 | 2907 | 0.050 |
Why?
|
Child | 4 | 2022 | 74388 | 0.050 |
Why?
|
Gene Duplication | 1 | 2022 | 337 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 272 | 0.050 |
Why?
|
Receptor, Insulin | 1 | 2005 | 871 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2021 | 204 | 0.050 |
Why?
|
Vidarabine | 1 | 2021 | 351 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2021 | 8805 | 0.050 |
Why?
|
Proteins | 1 | 2015 | 6166 | 0.050 |
Why?
|
Alleles | 2 | 2022 | 7101 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2021 | 360 | 0.050 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 761 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2019 | 308 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2022 | 72608 | 0.040 |
Why?
|
Biological Assay | 1 | 2022 | 658 | 0.040 |
Why?
|
Medulloblastoma | 1 | 2004 | 719 | 0.040 |
Why?
|
Pyrroles | 1 | 2005 | 1188 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2022 | 7056 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7223 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 595 | 0.040 |
Why?
|
Adolescent | 3 | 2015 | 85143 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 21811 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11336 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2004 | 1395 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2008 | 3433 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2022 | 1573 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2021 | 833 | 0.030 |
Why?
|
Reticulocytes | 1 | 2015 | 319 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2018 | 62344 | 0.030 |
Why?
|
United States | 2 | 2021 | 67804 | 0.030 |
Why?
|
Exons | 1 | 2020 | 2480 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 39891 | 0.030 |
Why?
|
Pathology | 1 | 2016 | 271 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 20654 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3714 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2004 | 5101 | 0.030 |
Why?
|
Endotoxins | 1 | 2015 | 560 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2015 | 874 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2020 | 5160 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2748 | 0.030 |
Why?
|
Gene Order | 1 | 2011 | 185 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 4921 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4594 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 1666 | 0.020 |
Why?
|
K562 Cells | 1 | 2011 | 637 | 0.020 |
Why?
|
Glioma | 1 | 2004 | 3299 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2004 | 2968 | 0.020 |
Why?
|
Spleen | 1 | 2015 | 2473 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2865 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2005 | 3249 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2020 | 2731 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2005 | 5495 | 0.020 |
Why?
|
Fetal Blood | 1 | 2015 | 1338 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29226 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4697 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 16693 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2013 | 1474 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2005 | 3991 | 0.020 |
Why?
|
Antibodies | 1 | 2015 | 2442 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2289 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5338 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 13262 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2011 | 14243 | 0.020 |
Why?
|
Borohydrides | 1 | 2005 | 35 | 0.020 |
Why?
|
Schiff Bases | 1 | 2005 | 26 | 0.020 |
Why?
|
Binding Sites | 2 | 2005 | 6295 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1416 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 18738 | 0.020 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 91 | 0.020 |
Why?
|
Allosteric Site | 1 | 2004 | 110 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9892 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39302 | 0.020 |
Why?
|
Apoptosis | 1 | 2020 | 10119 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 16404 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6777 | 0.010 |
Why?
|
Prospective Studies | 2 | 2021 | 51277 | 0.010 |
Why?
|
Catalysis | 1 | 2004 | 821 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6294 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 24744 | 0.010 |
Why?
|
Models, Chemical | 1 | 2004 | 648 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4329 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13301 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 10651 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 6134 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81128 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10802 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 8013 | 0.010 |
Why?
|
Protein Folding | 1 | 2004 | 865 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2005 | 2020 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 1013 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2004 | 12608 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 20097 | 0.010 |
Why?
|
Cytoplasm | 1 | 2004 | 1639 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2005 | 3873 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3568 | 0.010 |
Why?
|
Drug Design | 1 | 2004 | 1107 | 0.010 |
Why?
|
Animals | 3 | 2020 | 170894 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15271 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 41094 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2004 | 20086 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22929 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 4072 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2004 | 3707 | 0.010 |
Why?
|
Models, Molecular | 1 | 2004 | 5542 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8744 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 11276 | 0.010 |
Why?
|